Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parasitic Diseases

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    May 2023
  1. CASTANEDA-MOGOLLON D, Toppings NB, Kamaliddin C, Lang R, et al
    Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum.
    Antimicrob Agents Chemother. 2023 May 8:e0170922. doi: 10.1128/aac.01709.
    PubMed     Abstract available


  2. DEMARTA-GATSI C, Andenmatten N, Jimenez-Diaz MB, Gobeau N, et al
    Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model.
    Antimicrob Agents Chemother. 2023 May 3:e0157422. doi: 10.1128/aac.01574.
    PubMed     Abstract available


    April 2023
  3. PLATON L, Baker DA, Menard D
    Modified Plasmodium falciparum Ring-Stage Survival Assay with ML10 Kinase Inhibitor.
    Antimicrob Agents Chemother. 2023 Apr 26:e0001723. doi: 10.1128/aac.00017.
    PubMed     Abstract available


  4. REDHI D, Mulubwa M, Gibhard L, Chibale K, et al
    Integrating Pharmacokinetic-Pharmacodynamic Modeling and Physiologically Based Pharmacokinetic Modeling to Optimize Human Dose Predictions for Plasmodium falciparum Malaria: a Chloroquine Case Study.
    Antimicrob Agents Chemother. 2023 Apr 3:e0134522. doi: 10.1128/aac.01345.
    PubMed     Abstract available


    March 2023
  5. ROSILLO SR, Dimbu PR, Candido ALM, Oh JM, et al
    Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.
    Antimicrob Agents Chemother. 2023 Mar 14:e0160122. doi: 10.1128/aac.01601.
    PubMed     Abstract available


    January 2023
  6. RYAN KT, Wheeler NJ, Kamara IK, Johnson H, et al
    Phenotypic Profiling of Macrocyclic Lactones on Parasitic Schistosoma Flatworms.
    Antimicrob Agents Chemother. 2023 Jan 25:e0123022. doi: 10.1128/aac.01230.
    PubMed     Abstract available


  7. SINGH BK, Zhang C, Wu J, Peng YC, et al
    A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses.
    Antimicrob Agents Chemother. 2023 Jan 10:e0082122. doi: 10.1128/aac.00821.
    PubMed     Abstract available


    November 2022
  8. WICHA SG, Walz A, Cherkaoui-Rbati MH, Bundgaard N, et al
    New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations.
    Antimicrob Agents Chemother. 2022;66:e0055622.
    PubMed     Abstract available


  9. KAMIL M, Atmaca HN, Unal S, Kina UY, et al
    An Alternative Autophagy-Related Mechanism of Chloroquine Drug Resistance in the Malaria Parasite.
    Antimicrob Agents Chemother. 2022 Nov 7:e0026922. doi: 10.1128/aac.00269.
    PubMed     Abstract available


  10. OUOLOGUEM DT, Dembele L, Dara A, Kone AK, et al
    A Novel Ex Vivo Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes.
    Antimicrob Agents Chemother. 2022 Nov 2:e0100122. doi: 10.1128/aac.01001.
    PubMed     Abstract available


    October 2022
  11. NURKANTO A, Imamura R, Rahmawati Y, Prabandari EE, et al
    Dephospho-Coenzyme A Kinase Is an Exploitable Drug Target against Plasmodium falciparum: Identification of Selective Inhibitors by High-Throughput Screening of a Large Chemical Compound Library.
    Antimicrob Agents Chemother. 2022 Oct 31:e0042022. doi: 10.1128/aac.00420.
    PubMed     Abstract available


    September 2022
  12. GARG S, Kreutzfeld O, Chelebieva S, Tumwebaze PK, et al
    Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
    Antimicrob Agents Chemother. 2022 Sep 12:e0081722. doi: 10.1128/aac.00817.
    PubMed     Abstract available


    August 2022
  13. WESTERCAMP N, Owidhi M, Otieno K, Chebore W, et al
    Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
    Antimicrob Agents Chemother. 2022 Aug 29:e0020722. doi: 10.1128/aac.00207.
    PubMed     Abstract available


  14. TADELE G, Jaiteh FK, Oboh M, Oriero E, et al
    Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia.
    Antimicrob Agents Chemother. 2022 Aug 22:e0000222. doi: 10.1128/aac.00002.
    PubMed     Abstract available


  15. KANATANI S, Elahi R, Kanchanabhogin S, Vartak N, et al
    Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages.
    Antimicrob Agents Chemother. 2022 Aug 9:e0041822. doi: 10.1128/aac.00418.
    PubMed     Abstract available


    July 2022
  16. KUMAR A, Das S, Purkait B, Sardar AH, et al
    Correction for Kumar et al., "Ascorbate Peroxidase, a Key Molecule Regulating Amphotericin B Resistance in Clinical Isolates of Leishmania donovani".
    Antimicrob Agents Chemother. 2022 Jul 21:e0082922. doi: 10.1128/aac.00829.
    PubMed    


  17. RADOHERY GFR, Walz A, Gumpp C, Cherkaoui-Rbati MH, et al
    Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.
    Antimicrob Agents Chemother. 2022;66:e0011422.
    PubMed     Abstract available


  18. RAMALINGAM K, Gangwar S, Balodi DC, Anand A, et al
    Leishmania donovani Dipeptidylcarboxypeptidase Inhibitor as a Potential Oral Treatment for Visceral Leishmaniasis.
    Antimicrob Agents Chemother. 2022 Jul 19:e0236121. doi: 10.1128/aac.02361.
    PubMed     Abstract available


  19. SARAH-MATIO EM, Guillochon E, Nsango SE, Abate L, et al
    Genetic Diversity of Plasmodium falciparum and Distribution of Antimalarial Drug Resistance Mutations in Symptomatic and Asymptomatic Infections.
    Antimicrob Agents Chemother. 2022 Jul 6:e0018822. doi: 10.1128/aac.00188.
    PubMed     Abstract available


    April 2022
  20. MOORE CM, Wang J, Lin Q, Ferreira P, et al
    Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast.
    Antimicrob Agents Chemother. 2022 Apr 25:e0207921. doi: 10.1128/aac.02079.
    PubMed     Abstract available


    March 2022
  21. OKITWI M, Orena S, Thomas K, Tumwebaze PK, et al
    Impact of Short-Term Storage on Ex Vivo Antimalarial Susceptibilities of Fresh Ugandan Plasmodium falciparum Isolates.
    Antimicrob Agents Chemother. 2022 Mar 10:e0143721. doi: 10.1128/aac.01437.
    PubMed     Abstract available


  22. BERNEBURG I, Peddibhotla S, Heimsch KC, Haeussler K, et al
    An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase.
    Antimicrob Agents Chemother. 2022 Mar 10:e0210921. doi: 10.1128/aac.02109.
    PubMed     Abstract available


    January 2022
  23. YIPSIRIMETEE A, Chiewpoo P, Tripura R, Lek D, et al
    Assessment in vitro of the antimalarial and transmission blocking activities of Cipargamin and Ganaplacide in artemisinin resistant Plasmodium falciparum.
    Antimicrob Agents Chemother. 2022 Jan 3:AAC0148121. doi: 10.1128/AAC.01481.
    PubMed     Abstract available


    October 2021
  24. FERNANDEZ OL, Rosales-Chilama M, Quintero N, Travi BL, et al
    Potency and preclinical evidence of synergy of oral azole drugs and miltefosine in an ex vivo model of Leishmania (Viannia) panamensis infection.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0142521. doi: 10.1128/AAC.01425.
    PubMed     Abstract available


  25. KANAI M, Yeo T, Asua V, Rosenthal PJ, et al
    Comparative Analysis of Plasmodium falciparum Genotyping via SNP Detection, Microsatellite Profiling, and Whole-Genome Sequencing.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0116321. doi: 10.1128/AAC.01163.
    PubMed     Abstract available


  26. VELASQUEZ AMA, Bartlett PJ, Linares IAP, Passalacqua TG, et al
    New insights into the mechanism of action of the cyclopalladated complex - CP2 in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction and Cell Death.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0076721. doi: 10.1128/AAC.00767.
    PubMed     Abstract available


  27. PALOQUE L, Coppee R, Stokes BH, Gnadig NF, et al
    Mutation in Plasmodium falciparum BTB/POZ domain of K13 protein confers artemisinin resistance.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0132021. doi: 10.1128/AAC.01320.
    PubMed     Abstract available


    September 2021
  28. MANH ND, Thanh NV, Quang HH, Van NTT, et al
    Pyronaridine-Artesunate (Pyramax(R)) for the Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0027621. doi: 10.1128/AAC.00276.
    PubMed     Abstract available


  29. IMWONG M, Suwannasin K, Srisutham S, Vongpromek R, et al
    Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the Greater Mekong Subregion.
    Antimicrob Agents Chemother. 2021 Sep 13:AAC0112121. doi: 10.1128/AAC.01121.
    PubMed     Abstract available


    August 2021
  30. ELLIS KM, Lucantoni L, Chavchich M, Abraham M, et al
    The novel bis-1,2,4-triazine MIPS-0004373 demonstrates rapid and potent activity against all blood stages of the malaria parasite.
    Antimicrob Agents Chemother. 2021 Aug 30:AAC0031121. doi: 10.1128/AAC.00311.
    PubMed     Abstract available


  31. ETXEBESTE-MITXELTORENA M, Plano D, Espuelas S, Moreno E, et al
    New phosphoramidates containing selenium as leishmanicidal agents.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0059021. doi: 10.1128/AAC.00590.
    PubMed     Abstract available


  32. KREUTZFELD O, Rasmussen SA, Ramanathan AA, Tumwebaze PK, et al
    Associations between varied susceptibilities of PfATP4 inhibitors and genotypes in Ugandan Plasmodium falciparum isolates.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0077121. doi: 10.1128/AAC.00771.
    PubMed     Abstract available


  33. TALAAM KK, Inaoka DK, Hatta T, Tsubokawa D, et al
    Mitochondria as a potential target for the development of prophylactic and therapeutic drugs against Schistosoma mansoni infection.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0041821. doi: 10.1128/AAC.00418.
    PubMed     Abstract available


  34. PAKOSZ Z, Lin TY, Michalczyk E, Nagano S, et al
    Inhibitory compounds targeting Plasmodium falciparum Gyrase B.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0026721. doi: 10.1128/AAC.00267.
    PubMed     Abstract available


    July 2021
  35. VAN LOON W, Bergmann C, Habarugira F, Tacoli C, et al
    Changing pattern of Plasmodium falciparum multi-drug resistance-1 gene polymorphisms in southern Rwanda.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0090121. doi: 10.1128/AAC.00901.
    PubMed     Abstract available


    June 2021
  36. TAN S, Mudeppa DG, Kokkonda S, White J 3rd, et al
    Properties of Plasmodium falciparum with a deleted apicoplast DNA gyrase.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0058621. doi: 10.1128/AAC.00586.
    PubMed     Abstract available


  37. TABASSUM W, Singh P, Suthram N, Bhattacharyya S, et al
    Elevated DNA damage sensitivity in malaria parasite induced by the synergistic action between PfHsp90 inhibitor and PfRad51 inhibitor.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0045721. doi: 10.1128/AAC.00457.
    PubMed     Abstract available


  38. BESHIR KB, Diallo N, Some FA, Sombie S, et al
    Persistent sub-microscopic Plasmodium falciparum parasitaemia 72 hours after treatment with artemether-lumefantrine predicts 42-day treatment failure in Mali and Burkina Faso.
    Antimicrob Agents Chemother. 2021 Jun 1:AAC0087321. doi: 10.1128/AAC.00873.
    PubMed     Abstract available


    April 2021
  39. GOMES-ALVES AG, Duarte M, Cruz T, Castro H, et al
    Quinolin-(1H)-imines as a new chemotype against leishmaniasis: biological evaluation and mechanistic studies.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.01513.
    PubMed     Abstract available


  40. FENG J, Xu D, Kong X, Lin K, et al
    Characterization of pfmdr1, pfcrt, pfK13, pfubp1, and pfap2mu in travelers returning from Africa with Plasmodium falciparum infections reported in China from 2014-2018.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02717.
    PubMed     Abstract available


  41. DICKIE EA, Ronin C, Sa M, Ciesielski F, et al
    Towards chemical validation of Leishmania infantum ribose 5-phosphate isomerase as a drug target.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.01892.
    PubMed     Abstract available


  42. PERNAUTE-LAU L, Adegnika AA, Zhou Y, Zinsou JF, et al
    Pharmacogene sequencing of a Gabonese population with severe Plasmodium falciparum malaria reveals multiple novel variants with putative relevance for antimalarial treatment.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00275.
    PubMed     Abstract available


    March 2021
  43. BURGERT L, Zaloumis S, Dini S, Marquart L, et al
    Parasite-Host Dynamics throughout Antimalarial Drug Development Stages Complicate the Translation of Parasite Clearance.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


    February 2021
  44. LI H, Abraham A, Gazzola D, Hu Y, et al
    Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: